Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome)

BACKGROUND: Shenfu injection (SFI) has shown a remarkable therapeutic effect in patients with chronic heart failure (CHF) during the acute phase of symptom aggravation since it became commercially available in 1987. However, the therapeutic effect of SFI has not been validated in a standard clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xianliang, Zhao, Zhiqiang, Mao, Jingyuan, Du, Tinghai, Chen, Yuanping, Xu, Hao, Liu, Nan, Wang, Xiaolong, Wu, Jianguang, Li, Rong, Xu, Yong, Zhao, Yingqiang, Wang, Lei, He, Jingsong, Zhang, Junhua, Zhai, Jingbo, Zhao, Guoyuan, Hou, Yazhu, Wang, Shuai, Liu, Chunxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413379/
https://www.ncbi.nlm.nih.gov/pubmed/30930952
http://dx.doi.org/10.1155/2019/9297163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413379/
https://www.ncbi.nlm.nih.gov/pubmed/30930952
http://dx.doi.org/10.1155/2019/9297163

Ejemplares similares